167 related articles for article (PubMed ID: 36340608)
41. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
[TBL] [Abstract][Full Text] [Related]
42. Stress hormone norepinephrine incites resistance of oral cancer cells to chemotherapy.
Tjioe KC; Cardoso DM; Oliveira SHP; Bernabé DG
Endocr Relat Cancer; 2022 Mar; 29(4):201-212. PubMed ID: 35099408
[TBL] [Abstract][Full Text] [Related]
43. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells.
To KK; Yu L; Liu S; Fu J; Cho CH
Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497
[TBL] [Abstract][Full Text] [Related]
44. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
[TBL] [Abstract][Full Text] [Related]
45. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin.
Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida LO
Arch Oral Biol; 2022 Sep; 141():105468. PubMed ID: 35679799
[TBL] [Abstract][Full Text] [Related]
47. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC
Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963
[TBL] [Abstract][Full Text] [Related]
48. Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line.
Ketkaew Y; Osathanon T; Pavasant P; Sooampon S
Arch Oral Biol; 2017 Feb; 74():69-74. PubMed ID: 27886571
[TBL] [Abstract][Full Text] [Related]
49. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.
Bourguignon LY; Earle C; Wong G; Spevak CC; Krueger K
Oncogene; 2012 Jan; 31(2):149-60. PubMed ID: 21685938
[TBL] [Abstract][Full Text] [Related]
50. Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma.
Zhang G; Wang Z; Luo W; Jiao H; Wu J; Jiang C
Gastroenterol Res Pract; 2013; 2013():782581. PubMed ID: 24194752
[TBL] [Abstract][Full Text] [Related]
51. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
52. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
[TBL] [Abstract][Full Text] [Related]
53. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics.
Noto Z; Yoshida T; Okabe M; Koike C; Fathy M; Tsuno H; Tomihara K; Arai N; Noguchi M; Nikaido T
Oral Oncol; 2013 Aug; 49(8):787-95. PubMed ID: 23768762
[TBL] [Abstract][Full Text] [Related]
54. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
55. Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma.
Theile D; Gal Z; Warta R; Rigalli JP; Lahrmann B; Grabe N; Herold-Mende C; Dyckhoff G; Weiss J
Cancer Biol Ther; 2014 Apr; 15(4):436-42. PubMed ID: 24448417
[TBL] [Abstract][Full Text] [Related]
56. p38 Mitogen-activated protein kinase modulates cisplatin resistance in Head and Neck Squamous Cell Carcinoma cells.
Roy S; Roy S; Anuja K; Thakur S; Akhter Y; Padhi S; Banerjee B
Arch Oral Biol; 2021 Feb; 122():104981. PubMed ID: 33302041
[TBL] [Abstract][Full Text] [Related]
57. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
58. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
Tsunoda S; Okumura T; Ito T; Kondo K; Ortiz C; Tanaka E; Watanabe G; Itami A; Sakai Y; Shimada Y
Oncology; 2006; 71(3-4):251-8. PubMed ID: 17671398
[TBL] [Abstract][Full Text] [Related]
59. Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma.
Chu TS; Chen JS; Lopez JP; Pardo FS; Aguilera J; Ongkeko WM
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):979-84. PubMed ID: 18794444
[TBL] [Abstract][Full Text] [Related]
60. Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.
Li XX; Dong Y; Wang W; Wang HL; Chen YY; Shi GY; Yi J; Wang J
Stem Cells Dev; 2013 Feb; 22(4):554-66. PubMed ID: 22974371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
